Skip to main content

HemOnc: CLL/SLL

Trial ID
05168930
Trial Sponsor
Dana Farber Cancer Institute

HemOnc: CLL/SLL (DFCI 21-279)

Description: A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients